RT Journal Article
SR Electronic
T1 Circulating pancreatic enzyme levels are a causal biomarker of type 1 diabetes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.08.08.24311619
DO 10.1101/2024.08.08.24311619
A1 Elgamal, Ruth M
A1 Melton, Rebecca L.
A1 Chiou, Joshua
A1 McGrail, Carolyn W
A1 Gaulton, Kyle J
YR 2024
UL http://medrxiv.org/content/early/2024/08/09/2024.08.08.24311619.abstract
AB Novel biomarkers of type 1 diabetes (T1D) are needed for earlier detection of disease and identifying therapeutic targets. We identified biomarkers of T1D by combining plasma cis and trans protein QTLs (pQTLs) for 2,922 proteins in the UK Biobank with a T1D genome-wide association study (GWAS) in 157k samples. T1D risk variants at over 20% of known loci colocalized with cis or trans pQTLs, and distinct sets of T1D loci colocalized with immune, pancreatic secretion, or gut-related proteins. We identified 23 proteins with evidence for a causal role in using pQTLs as genetic instruments in Mendelian Randomization which included multiple sensitivity analyses. Proteins increasing T1D risk were involved in immune processes (e.g. HLA-DRA) and, more surprisingly, T1D protective proteins were enriched in pancreatic secretions (e.g. CPA1), cholesterol metabolism (e.g. APOA1), and gut homeostasis. Genetic variants associated with plasma levels of T1D-protective pancreatic enzymes such as CPA1 were enriched in cis-regulatory elements in pancreatic exocrine and gut enteroendocrine cells, and the protective effects of CPA1 and other enzymes on T1D were consistent when using instruments specific to acinar cells. Finally, pancreatic enzymes had decreased acinar expression in T1D, including CPA1 which was altered prior to onset. Together, these results reveal causal biomarkers and highlight processes in the exocrine pancreas, immune system, and gut that modulate T1D risk.Competing Interest StatementK.J.G has done consulting for Genentech, received honoraria from Pfizer, and holds stock in Neurocrine biosciences. J.C. holds stock in and is employed by Pfizer Inc.Funding StatementThis work was supported by NIH grant DK105554, the Larry L Hillblom foundation, and the Winker Endowment in Type 1 Diabetes Research to K.J.G.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the University of California San Diego gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesSummary statistics for the T1D GWAS meta-analysis without UKB samples has been deposited into the NHGRI-EBI GWAS catalogue with accession number GCP000982. Protein QTL summary statistics from the UKB-PPP are available at https://www.synapse.org/Synapse:syn51364943/wiki/622119 and fine-mapping of pQTLs can be found in the following manuscript https://doi.org/10.1038/s41586-023-06592-6. Cell type cREs are available as part of the Cis-Element Atlas (CATlas) http://catlas.org/catlas_hub/.